News

HDA UK Media and Political Bulletin – 27 July 2021

Media Summary

UK rejects EU’s Northern Ireland ‘solutions’
POLITICO, Hans von der Burchard, 26 July 2021

POLITICO reports that the UK has rejected the European Commission’s latest proposals to alleviate trade friction in relation to the Northern Ireland Protocol, after a “non-paper” on medicines was published by the European executive on Monday. It is understood that this document contains the same proposals as set out by the European Commission in late June.

The proposed solution would situate EU regulatory compliance functions in Great Britain, with the caveat that affected medicines would only be distributed to Northern Ireland. This would require “enhanced enforcement” from the UK competent authorities to ensure that medical products are not further distributed within the European single market.

A UK Government spokesperson stated that “The EU’s proposal was a welcome start but it would be complex to operate, onerous and would not deal at all with those medicines, such as new cancer drugs, which under current arrangements must be licensed by the European Medicines Agency in Northern Ireland. That is why we have proposed in our Command Paper that the simplest way forward in order to avoid these problems in future is to remove medicines from the scope of the [Northern Ireland] Protocol altogether.”

 

 Parliamentary Coverage

 

There was no parliamentary coverage today. 

 

Full Coverage

UK rejects EU’s Northern Ireland ‘solutions’
POLITICO, Hans von der Burchard, 26 July 2021

The U.K. on Monday rejected the European Commission’s proposals for “solutions” to ease trade friction between Northern Ireland and mainland Britain, which Brussels set out in two so-called non-papers published earlier the same day.

The two papers, which had previously been shared with the U.K. government as well as EU countries, include proposals covering medicines as well as food safety checks — also known by the technical term sanitary and phytosanitary measures (SPS) — and the movement of assistance dogs for disabled people.

However, the two non-papers had already previously been sent to the British government — the document on medicines went in June — and the two sides remain locked in a dispute over how to solve trade problems between Northern Ireland and Britain. A U.K. spokesperson said the papers did not address all the problems and called for “comprehensive and durable solutions.”

Last week, British Prime Minister Boris Johnson said the current trade set-up in the post-Brexit Northern Ireland protocol is “unsustainable” and called for a renegotiation — an appeal that Commission President Ursula von der Leyen immediately rejected.

The non-paper on medicines proposes changes to the EU’s own rules so that regulatory compliance functions, such as quality control tests, could be permanently conducted in Great Britain as long as it can be ensured that relevant medicines are only distributed to Northern Ireland and not further into the EU.

The Commission says this would “ensure a continued, long-term supply of medicines in Northern Ireland” as it had been “too costly for certain operators currently based in Great Britain” to move the regulatory approval procedures to Northern Ireland or the EU, as was foreseen by the initial treaty.

Yet the U.K. government spokesperson said late Monday: “The solution the EU has set out today remains the same as the one they sent to us in late June — the EU has not addressed the issues and concerns that we have raised with them.

“The EU’s proposal was a welcome start but it would be complex to operate, onerous and would not deal at all with those medicines, such as new cancer drugs, which under current arrangements must be licensed by the European Medicines Agency in Northern Ireland. That is why we have proposed in our Command Paper that the simplest way forward in order to avoid these problems in future is to remove medicines from the scope of the [Northern Ireland] Protocol altogether.”

The second non-paper includes proposals “to ease the movement of assistance dogs accompanying persons travelling from Great Britain to Northern Ireland,” as well as “to simplify the movement of livestock” between both parts, according to the Commission. The document further seeks “to clarify the rules on EU-origin animal products that are moved to Great Britain for storage before being shipped to Northern Ireland.”

The U.K. spokesperson commented on the second non-paper: “What the EU is presenting as a package of solutions is in fact only a small subset of the many difficulties caused by the way the Protocol is operating. We need comprehensive and durable solutions if we are to avoid further disruption to everyday lives in Northern Ireland — as we have set out in our Command Paper.”

Commission Vice President Maroš Šefčovič, the EU’s Brexit point person, said the solutions “were brought about with the core purpose of benefitting the people in Northern Ireland,” adding that “our work is about ensuring that the hard-earned gains of the Good Friday (Belfast) Agreement.”

HDA UK Media and Political Bulletin –  27 July 2021

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?